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Abstract
Although an indomethacin-induced decrease of brain perfu­
sion in preterm infants has been well established, the acute 
effects of this vasoactive drug on cerebral hemodynamics and 
oxygenation are not well documented. Using near infrared 
spectroscopy we monitored in 6 very preterm infants changes 
in cerebral blood volume (ÁCBV) and cytochrome oxidase 
concentration (ACytaaj), used as relative measures o f changes 
in brain perfusion and as an indicator for cellular oxygenation 
of brain tissue, during and up to 1 h after indomethacin infu­
sion. ACBV showed a quick blood-pressure-related increase as 
compared to baseline (preindomethacin values) during indo­
methacin infusion (averaged maximal increase 13%), followed 
by a sharp decrease below baseline values (averaged maximal 
decrease 24%). There was a sustained recovery to baseline 
during the registration period. ACytaaj showed a small, early 
increase in 4 of 6 babies, followed by a substantial decrease 
below baseline in 5 babies. ACytaa3 showed only a partial 
recovery in those 5 babies during the study period. We con­
clude that a therapeutic dose of indomethacin may cause sub­
stantial swings in brain perfusion and a marked and rather 
longstanding decrease in Cytaa3 , suggesting a decrease in cellu­
lar oxygenation of brain tissue. Awareness of these effects may 
be important in sick preterm babies during periods of pulmo­
nary and cardiac instability.
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University Hospital Leiden S. Knrger ACJ, Bnscl
Neonatal Unit. Ihiiiding 1-J9-R 0006-3126/95/
PO Box 9600 0682-009 lSH.00/0 
NL-2300 RC Leiden (The Netherlands)
Introduction
Indomethacin, a prostaglandin inhibitor, 
has been used extensively for nonin vasive clo­
sure of a hemodynamically important patent 
ductus arteriosus (PDA) in the preterm in­
fant. Indomethacin has a constrictive action 
on the vascular beds of important organ sys­
tems in the newborn animal and human neo­
nate [1-4], Several studies showed an increase 
of the resistance of the cerebral vascular bed 
with a subsequent decrease in brain blood 
flow up to 40% for at least 1 h after adminis­
tration of a therapeutic dose of indomethacin 
to preterm babies [2, 5],
Although immediate significant increases 
in arterial blood pressure have been reported 
during indomethacin infusion in experimen­
tal and clinical studies [6, 7], the impact of 
these acute hemodynamic pertubations on the 
preterm cerebral circulation, which has a vul­
nerable autoregulation [8], and on metabo­
lism, is not well documented.
We therefore monitored cerebral perfusion 
and cellular oxygenation of brain tissue in 6 
preterm babies, using near infrared spectros­
copy (NIRS), during and up to 1 h after intra­
venous infusion of 0.1 mg/kg indomethacin.
Patients and Methods
The study was performed on preterm infants, who 
received an initial intravenous dose o f 0.1 mg/kg of 
indomethacin for non in vasi ve closure of PDA. The 
indomethacin was infused over a 5-min period. The 
diagnosis o f PDÀ was made on clinical symptoms and 
radiographic features, and confirmed by Doppler 
echoeardiographic investigation. Informed parental 
consent was obtained in all infants. The study was 
approved by the scientific board of the Department of 
Pediatrics.
Oxygenation by NIRS
The head of the neonate is relatively transparent to 
near infrared light. Hemoglobin (Hb) and cytochrome
oxidase (the terminal member of the mitochondrial 
respiratory chain) are natural chromophores and both 
have an oxygenation-dependent absorption in this 
wavelength region. By selection of the appropriate 
wavelength, algorithms have been developed to con­
vert absorption changes into changes in concentra­
tion of oxygenated Hb (AHbC^), deoxygenated Hb 
(AHbR), total Hb (AHbtot = AH b02 + AHbR) and cyto­
chrome oxidase (ACytaa^) in mmol/1 [9, 10]. Quantifi­
cation o f the NIRS variables into absolute concentra­
tion changes presupposes that the pathlength is known. 
The interoptodc distances in the present study ranged 
from 5 to 6 cm. The optical pathlength is supposed to 
be considerably greater than the interoptodc distance, 
due to significant scattering of light in brain tissue. 
Similar to earlier studies by others we assumed an opti­
cal pathlength of 4.4 times the interoptodc distance [9]. 
The NIRS instrument used (Radiometer, Copenhagen, 
Denmark), consisted of four semiconductor laser 
diodes with wavelengths of 904, 845, 805 and 775 nm. 
The lasers were operated sequentially, and pulsed with 
a repetition rate of 500 Hz for 200 ns. We placed the 
transmitting and receiving optodes on the parietal- 
frontal regions on both sides of the head above the ear, 
Changes in optode position will cause changes in path­
length which results in absorption changes not related 
to changes in cerebral blood or tissue oxygenation. We 
therefore used a proper fixation method of the optodes 
as described earlier [11]. The energy emitted by each 
diode was well within the orders of the British Stan­
dards Institute safety limits (BS 4803).
Relative changes in cerebral blood volume (ACBV) 
were calculated using the following equation: ACBV = 
AHbtot X 0.89/ [Hb], where [Hb] is the large vessel 
hemoglobin concentration in g/dl [12]. Changes in 
ACBV are thus relative changes from the baseline val­
ue and expressed in m l/100 g brain tissue. Earlier stud­
ies showed a good relationship with changes in actual 
brain blood flow, determined with the l33Xe clearance 
method [10, 13]. We therefore considered that ACBV 
indicated changes in brain perfusion, if changes in 
ACBV were caused predominantly by changes in 
AHbCh. ACytaa.i is supposed to indicate changes in the 
oxidation level of the intraccrcbral mitochondrial en­
zyme cytochrome oxidase and has been used as a rela­
tive measure o f brain cell oxygenation [12, 14], 
Changes in ACytaa3 are thus relative changes from the 
baseline value and are expressed in mmol/1.
Study Design, Data Collection and Analysis
NIRS registrations started at least 30-60 min be­
fore the start of the study to exclude the possibility o f  
system drift. Indomethacin infusion started at the mo-
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ment a stable baseline was reached for at least 5 -  
10 min. The recordings ended 1 h after the completion 
of the indomethacin infusion.
Changes relative to baseline in HbC>2 (AHbC>2), 
HbR (AHbR), Hbiot and Cytaa3 (ACytaa3) were deter­
mined every 4 s and stored in a personal computer for 
off-line analysis and calculation of ACBV. Transcuta- 
neous-derived arterial PO2 and PCO2 (tcPC>2 and 
tcPCCh), and arterial blood pressure from an indwell­
ing catheter (2 patients) were simultaneously deter­
mined every 4 s and stored in the computer. In 4 
patients blood pressure was measured using an oscil- 
lometric method (Dynamap, Criterion, Tampa, Fla,, 
USA) just before the start o f indomethacin infusion 
and then every 2 min up to 6 min, until completion of 
the infusion. Further on, blood pressures in these 4 
infants were measured at 10, 20, 30 40, 50, and at 
60 min after the start of indomethacin infusion. He­
matocrit was determined at regular intervals.
Statistical Analysis
For statistical purposes the 4-second interval val­
ues of ACBV, ACytaa3, mean arterial blood pressure 
(MABP), tcP02, and tcPCC>2 were averaged per 2-min 
time interval. Because it appeared from our data (see 
‘results’) that changes in arterial blood pressure during 
indomethacin infusion might play an important role in 
the simultaneously detected changes in ACBV and 
ACytaa3 , we evaluated the relation between the various 
variables during indomethacin infusion (0-6 min) sep­
arately from those obtained after completion of the 
indomethacin infusion (7-60 min).
To investigate which factor(s) was (were) responsi­
ble for the changes in ACBV or ACytaa^ during indo- 
methacin infusion, we selected those variables which 
are known to be involved in brain perfusion: MABP, 
tcPOa and tcPC02. We used the (averaged) values of 
these variables collected at baseline, and at 1-2, 3-4  
and 5-6  min after the start of indomethacin infusion. 
A multiple linear regression model was used. The 
regression equation was:
Y = b0 + b^Aiir * MABP + brcKvTcPOs +
bTcPCxv TCPCO2 +■ £aivlvn
where ACBV or ACytaa3 arc the dependent variables 
and b0 its mean over all the runs. The MABP, tcPO 
and tcPC 02 were taken as independent variables. 
These independent variables were either introduced or 
removed from the equation, based on their signifi­
cance level (p < 0.05). To assess the interpatient vari­
ability (IV) five patient variables for the 6 patients 
were also introduced as independent variables. The 
patients were coded using the effect coding technique
[15], This coding for interindividual (patient) variabil­
ity was primarily done to account for potential con­
founding variables that might obscure the effect of the 
chosen independent variables. The overall model was 
tested on significance by an F test and related p value. 
The R2 o f the regression equation gives the correlation 
between the predicted ACBV/ACytaa3 , based on the 
independent variables of this regression model and the 
actual ACBV/ACytaa3 values. In other words: how well 
the model fits the data. Furthermore, each indepen­
dent variables was tested whether it had a significant 
effect on ACBV/ACytaa3 by a partial F test and related 
p value. A more detailed explanation has been given by 
Glantz and Slinker [ 15J*
To investigate a possible relation between brain 
perfusion (ACBV) or oxygenation (ACytaa3), MABP 
and tcP02 and tcPCC>2 after the completion of the 
indomethacin infusion, we repeated the multiple li­
near regression model as described above. We used the 
(averaged) values of these values collected at 10, 20, 
30,40, 50 and 60 min after the start of the indometha­
cin infusion.
To further elucidate the (individual) relationship 
between MABP and ACBV (see ‘results’), we used sim­
ple linear regression analysis. To test whether or not a 
curvilinear fit showed a better correlation as compared 
to linear regression, we used a polynominal regression 
analysis.
Differences between hemodynamic variables and 
extra oxygen need before indomethacin and at 5, 30 
and 60 min were investigated by analysis of variance 
for repeated measurements followed by Scheffe’s F test 
if statistically significant differences were obtained. To 
investigate whether or not intraindividual differences 
between pre- and 12 h postindomethacin hematocrit 
existed, the Student’s t test for paired observations was 
used, p values of less than 0.05 were considered statis­
tically significant.
Results
Nine patients were initially included in the 
study. In 3 of these 9 patients it was not possi­
ble to obtain reliable NIRS recordings for at 
least 1 h (2 patients) or reliable blood pressure
measurements (1 patient). The remaining 6 
patients all met the clinical signs for PDA 
(characteristic murmur, bounding pulses, hy­
perdynamic précordium) and Doppler echo-
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cardiographie investigation confirmed PDA: 
a diastolic reverse flow in the main pulmo­
nary artery with a predominantly left-to-right 
flow through the ductus arteriosus. Moreover, 
all infants were mechanically ventilated (In­
fant star, Infrasonics Inc,, San Diego, Calif, 
USA) and none of them could be weaned 
from the ventilator. The patient characteris­
tics of these 6 infants are shown in table 1. 
During the study period, the infants were sta­
ble and no major changes in ventilator set­
tings were necessary, Table 2 gives PDA-relat- 
ed data (mean values ± SD of MABP, pulse 
pressure, heart rate and extra oxygen need) as 
a function of time. Only MABP upon comple­
tion of the indomethacin infusion was signifi­
cantly higher as compared to the MABP be­
fore indomethacin administration. The other 
variables did not differ during the study peri­
od. tcPC>2 values were stable in each infant 
and within the normal range (mean ±  SD; 61 
± 1 1  mm Hg), tcPC02 values were slightly 
elevated in 2 infants but stable in each infant 
(mean ± SD: 52 ±  6 mm Hg), Individual 
hematocrit values did not differ before indo­
methacin infusion as compared to values 12 h 
after its administration.
Individual Patterns o f  ACBV and ACytaa . 3  
Individual patterns of ACBV and ACytaa3 
are shown in figure 1. There was a biphasic 
response of ACBV after indomethacin admin­
istration: A variable but quick increase in 
ACBV in 5 of the 6 patients (patients 1-5) as 
compared to baseline during indomethacin- 
infusion with an average maximal increase of
0,4 m l/100 g brain tissue, followed by a de­
crease below baseline in all patients after com­
pletion of the infusion (average maximum 
decrease: 0.6 ml/100 g brain tissue). These 
changes were almost exclusively caused by
Table 1. Patient characteristics
Patient No. GA, weeks BW .g Age, days
1 25.3 835 20
2 30.6 1,835 9
3 25.0 672 20
4 28.6 900 25
5 30,9 1,730 6
6 27.0 1,000 7
Mean ±  1 SD 27,9±2.3 1,162±450 14.5 ±7.4
Table 2. Mean values ±  SD of MABP, pulse pressure, heart rate and extra oxygen need 
(FÌO2) asa function of time
-------------------------11------ I---- lí---------------- Ifl------THl--------I----------- Mil .........................................  ill i i i i i ............ ........................ .. I■ I________ _________________ ______ O f ................ .............................. .............. .... .................. . ... i i i n i l  .........  IH  TT li ft 1
Before After indomethacin
indomethacin ; — :--------— — :------------ 7 Z ~ .------ -
5 mm 30 min 60 mm
MABP, mm Hg 35 ±3 46 ±6* 40 ± 2 41 ±5
Pulse pressure, mm Hg 26 ±5 23 ± 8 24 ± 6 26 ± 6
Heart rate 154 db 13 145± 15 150± 11 149 ±10
F i0 2 0.43 ±0.18 0.45 ±0.21 0.39 ±0.18 0.40 ±0.17
* p < 0,01 vs, before indomethacin.
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Fig, 2. a Individual relation­
ships between MABP and ACBV 
during indomethacin infusion us­
ing linear regression analysis, 
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methacin infusion using a 3rd-or- 
der polynominal regression analy­
sis.
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changes in AHbCh. Four patients showed a 
(mostly) sustained recovery to baseline during 
the recording time, but in the 2 other patients 
ACBV was well below baseline at the end of 
the NIRS registrations. ACytaa  ^ showed a
small early increase in 4 of the 6 babies (aver­
age maximum increase: 0.9 mmol/1) and a de­
crease well below baseline in 5 babies with no 
or an incomplete recovery to baseline at the 
end of the registration period (average max.i-
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mum decrease: 3 mmol/1). One patient showed
a second persistent increase in ACytaa3 as 
compared to base line value from 10 min pos- 
tindomethacin.
Relationship between ACBV or ACytaa j, 
and MABP, tcPÖ2, and tcPCOi during 
Indomethacin Infusion 
We were able to construct significant re­
gression models for both ACBV and ACytaa3 
(p values equations; <0.05 and <0.05). Only 
MABP appeared to be a significant predictor 
of ACBV (partial F value: 8.12, p < 0.05), 
whereas tcPÛ2 and tcPC02 did not. There 
was no relation between ACytaa3 , and MABP, 
tcP02, or tcPC02. In both equations (ACBV 
and ACytaa3) the interpatient variability was 
not significant.
Figure 2a shows the individual relation­
ships between MABP and ACBV. The correla­
tion coefficients (r) ranged from 0.56 to 0.98. 
The overall correlation coefficient appeared 
to be 0.74 (p <  0.0001), but increased to 0.86 
(p < 0.0001) when a curvilinear fit was used 
(3rd order polynominal regression analysis). 
This curvilinear relationship is shown in fig­
ure 2b.
Relationship between ACB V or ACytaa j, 
and MABP, tcPOì, and tcPCOi after 
Completion of Indomethacin Infusion 
Onward
Also here we were able to construct signifi­
cant regression models for both ACBV and 
ACytaa3  (p values equations; <0.01 and 
<0.01). MABP, tcP02 or tcPC02 had no in­
fluence on ACBV or ACytaa3 during the re­
mainder of the study period. It must be men­
tioned, however, that MABP, tcP02 and 
tcPC02 were rather stable during this part of 
the study. The interpatient variability was sig­
nificant in both equations (ACBV: F set 
40.18, p < 0.0001; ACytaa3: F set 10.51, p < 
0.001).
Discussion
Although the magnitude of the individual 
changes were quite variable, the present study 
showed that intravenous infusion of indo­
methacin induced an arterial blood pressure- 
related increase of ACBV, whereas after the 
completion of the infusion ACBV decreased 
well below baseline in almost all patients. 
Assuming that normal CBV in these preterm 
babies is in the order of 2.5-3.5 ml/100 g 
brain tissue [12, 16], this means an approxi­
mately 13% increase and 24% decrease of 
CBV, respectively. As far as changes in CBV 
reflect changes in actual brain blood flow, the 
present study indicates substantial indometh- 
acin-induced swings of brain perfusion in at 
least some of these preterm babies.
Although indomethacin has been shown to 
enhance the autoregulatory ability of the neo­
natal cerebral vascular bed [17], an initial, 
arterial blood pressure related increase in 
brain perfusion during indomethacin infu­
sion, suggesting lack of cerebral autoregula­
tion, has not yet been reported. Experimental 
studies report that the autoregulatory ability 
of the cerebral vascular bed is already opera­
tive in early fetal life, but that the autoregula­
tory range is narrow and resting cerebral per­
fusion pressure is very near its lower limit [18, 
19]. Also in very preterm infants less than 32 
weeks of gestation with a postnatal age be­
tween 12 and 72 h, cerebral autoregulation 
has been reported, again only over a narrow 
range (from 32 to 41 mm Hg) of mean arterial 
pressures [8]. Another study in preterm babies 
reported similar findings [20]. Although regu­
latory ability improves with advancing gesta­
tional and postnatal age and the range of 
blood pressures at which brain perfusion is 
constant is higher in more mature newborns 
[19, 21], Lou et al. [22] reported that especial­
ly in distressed (preterm) babies cerebral au­
toregulatory ability was often impaired. Fig-
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ure 2a shows the individual best Fits between creases brain tissue oxygenation in pulmo-
ACBV and MABP of our study group dur- nary and hemodynamically stable preterm
ing indomethacin infusion by linear regres- newborns [26], However, there is some con-
sion analysis. It can be questioned, however, cern that ACytaap, does not properly reflect
whether or not this is the appropriate manner changes in brain cell oxygenation. The use of
to analyse these data for all patients: For wrong algorithms for calculation of changes in
instance, in patients 1, 3 and 4 the highest ACytaa3 [ 10] and the low energy requirement
MABP values may have exceeded the upper of the brain cell in the preterm neonate may
limit at which autoregulation of the cerebral mask fluctuations in the oxidation-reduction
circulation was still operative, whereas in pa- level of cytochrome oxidase [27] and affect
tient 5, the patient with the most advanced the reliability of ACytaa.i as a marker of actual
gestational age, the pattern of MABP-related changes in oxidation of the enzyme cyto-
changes suggests that the pre-indomethacin chrome oxidase.
MABP was below the lower limit of autoregu- It is less likely that the hemodynamic
latory ability of the cerebral vascular bed. In all changes, including the changes in ACBV, were
instances a curvilinear fit rather than a linear related to an indomethacin-induced (tran-
fit might be more appropriate. This is support- sient) ductus arteriosus closure. In earlier stud-
ed by the curvilinear fit of the pooled results ies in preterm infants, we found that the clini-
shown in figure 2b, which in fact show a blood- cal signs of PDA subsided only 4 h after indo-
pressure-independent brain perfusion of be- methacin administration [2,3]. Moreover, in a
tween 3 5 and 42 mm Hg, surprisingly similar very recent study in 20 preterm infants, in
to earlier studies in preterm newborns with which we assessed the influence of indometha-
comparable gestational age [8]. However, our ein on cardiac and pulmonary hemodynamics,
data must be interpreted with caution because it appeared that ductal patency and pulmonary
of the small study population and heterogenic- hemodynamics were not effected after indo-
ity in gestational and postnatal age. methacin treatment until 4 h after its adminis-
The subsequent decrease in brain perfu- tration [28]. The (hemodynamic) data shown
sion confirms earlier studies in newborn ani- in table 2 also suggest that no important alter-
mals and preterm babies. In all these studies a ations occurred with respect to ductal patency
decrease in brain blood flow (velocity) was during the study period.
reported up to 40 % of pre-indomethacin val- Despite the results of the present study,
ues and lasting up to 2 h after indomethacin indomethacin will remain an important drug
administration [2, 5,23, 24]. Although recent for noninvasive closure of PDA. Moreover, its
studies showed a beneficial effect of early use for prevention of severe intraventricu-
indomethacin treatment in very preterm ba- lar hemorrhages [20] seems very promising,
bies with regard to periventricular-intraven- We propose, however, very slow infusion
tricular hemorrhages [25], Leffler et al. [1] rates of indomethacin to avoid as far as pos-
showed that cerebral oxygen consumption sible blood-pressure-related acute increases
was decreased in hypotensive piglets that in brain blood flow [26]. Furthermore, one
were treated with therapeutic dosages of indo- should be aware that an indomethacin-in-
methacin. As far as ACytaa3 indicates changes duced decrease in brain perfusion and oxy-
in cellular oxygenation of brain tissue, our genation in the sick preterm babies may com-
study provides further evidence that the indo- promize cerebral metabolism during periods
methacin-induced drop in brain perfusion de- of pulmonary and cardiac instability.
98 Bcndcrs/Dorrepaal/van dc Bor/van Bel Acute Effect of Indomethacin
References
1 Leffler CW, Busija DW, Beasley
DG: Effect of therapeutic dose of 
indomethacin on the cerebral circu­
lation of newborn pigs. Pediatric 
Res 1987;21:188-192.
2 van Bel F, van de Bor M, Stijnen T, 
Baan J, Ruys JH: Cerebral blood 
flow velocity changes in preterm in­
fants after a single dose of indo­
methacin: Duration of its effect. Pe­
diatrics 1989;84:802-807.
3 van Bel F, van Zoeren D, Schipper J, 
Guit GL, Baan J; Effect of indo­
methacin on superior mesenteric ar­
tery blood flow velocity in preterm 
infants. J Pediatr 1990;116:965- 
970.
4 van Bel F, Guit GL, Schipper J, van 
de Bor M: Indomethacin-induced 
changes in renal blood flow velocity 
wave form in premature infants in­
vestigated with color Doppler imag­
ing. J Pediatr 1991 ; 118:621-626.
5 Pryds O, Greiseil G, Johansen KH: 
Indomethacin and cerebral blood 
flow in preterm infants treated with 
patent ductus arteriosus. Eur J Pe­
diatr 1988;147:315-316.
6 Leffler CW, Busija DW, Beasley 
DG, Fletcher AM, Green RS: Ef­
fects o f  indomethacin on cardiac 
output distribution in normal and 
asphyxiated piglets. Prostaclandins 
1986;31:183-190.
7 Evans N, Iyer P: Change in blood 
pressure after treatment of patent 
ductus arteriosus with indometha­
cin. Arch Dis Child 1993;68:584- 
587.
8 Van de Bor M, Walther F: Cerebral 
blood flow velocity regulation in 
preterm infants. Biol Neonate 1991; 
59:329-335.
9 Wray S, Cope M, Wyatt JS, Rey­
nolds EOR: Characterization of the 
near infrared absorption spectra of 
cytochrome aa^ and haemoglobin 
for the non-in vasi ve monitoring of 
cerebral oxygenation. Biochim Bio­
phys Acta 1988;933:184-192.
10 Pryds O, Greisen G, Skov LL, Friis- 
Hansen B: Carbon dioxide-related 
changes in cerebral blood volume 
and cerebral blood flow in mechani­
cally ventilated preterm neonates: 
Comparison of near infrared spec­
troscopy and xenon-133 clearance. 
Pediatr Res 1990;27:445-449.
11 Liem KD, Oesenburg B, Hopman 
JCW: Method of the fixation of op­
todes in near infrared spectropho­
tometry. Med Biol Eng Comput 
1992;30:120-121.
12 Wyatt JS, Edwards AD, Cope M, 
Delpy T, McCormick DC, Potter A, 
Reynolds EOR: Response of cere­
bral blood volume to changes in ar­
terial carbon dioxide tension in pre­
term and term infants. Pediatr Res 
1991;29:553-557.
13 Skov LL, Pryds O, Greisen G: Esti­
mating cerebral blood flow in new­
born infants: Comparison of near in­
frared spectroscopy and xenon-133 
clearance. Pediatr Res 1991 ;30: 
570-573.
14 Brazy JE, Lewis DV: Changes in ce­
rebral blood volume and cyto­
chrome aa^ during hypertensive 
peaks in preterm infants. J Pediatr 
1986;108:983-987.
15 Glan tz  S, SI inker BK: Primer of Ap­
plied Regression and Analysis of 
Variance. New York, McGraw-Hill, 
1990, pp 777-789.
16 Brun NC, Greisen G: Cerebrovascu­
lar responses to carbon dioxide as 
delected by near-infrared spectro­
photometry: Comparison of three 
different measures, Pediatr Res 
1994;36:20-24.
17 Van Bel F, Klautz RJM, Steendijk 
P, Schipper IB, Teitel DF, Baan J: 
The influence of indomethacin on 
the autoregulatory ability of the ce­
rebral vascular bed in the newborn 
lamb. Pediatr Res 1993;34:178- 
181.
18 Papile LA, Rudolph AM, Heymann 
MA: Autoregulation of cerebral 
blood flow in the preterm fetal lamb.
Pediatr Res 1985;19:159-161.
19 Szymonowicz W, Walker AM, Yu 
VYH, Stewart ML, Cannata J, Cuss- 
en L: Regional cerebral blood (low 
after hemorrhagic hypotension in 
the preterm, near-term, and new­
born lamb. Pediatr Res 1990;28: 
361-366.
20 Greisen G, Trojaborg W: Cerebral 
blood flow, PaCC>2 changes, and vi­
sual evoked potentials in mechani­
cally ventilated preterm infants, 
Acta Paediatr Scand 1987;76:394- 
398.
21 Altman DI: Cerebral blood (low in 
premature infants: Regulation, mea­
surement, and pathophysiology of 
in tra ventricular hemorrhage; in Pol­
in, Fox (eds): Fetal and Neonatal 
Physiology, Philadelphia, Saunders, 
1992, vol II, pp 1587-1597.
22 Lou HC, Lassen NA, Friis-Hanscn 
B: Impaired autoreguiation of cere­
bral blood flow in the distressed 
newborn infant. J Pediatr 1979;94: 
118-121.
23 Leffler CW, Busija DW, Fletcher 
AM, Beasly DG, Hessler JR, Green 
RS: Effects of indomethacin upon 
cerebral hemodynamics of newborn 
pigs. Pediatr Res 1985; 19:1160- 
1164.
24 Ohlsson A, Bottu J, Govan J, Ryan 
ML, Fong K, Myhr T : Effect of indo­
methacin on cerebral blood flow ve­
locities in very low birth weight neo­
nates with a patent ductus arterio­
sus. Dev Pharmacol Ther 1993;20: 
100-106.
25 Ment LR, Oh W, Ehrenkranz RA, 
Philip AGS, Vohr B, Allan W, Dun­
can CC, Scott DT, Taylor KJW, 
Katz KH, Schneider KC, Makuch 
RW: Low-dose indomethacin and 
prevention of intra ventricular hem­
orrhage: A multiccnter randomized 
trial. Pediatrics 1994;83:543-550.
26 Edwards AD, Wyatt JS Richardson 
C, Potter A, Cope M, Delpy DT, 
Reynolds EOR: Effects of indo­
methacin on cerebral haemodynam- 
ics in very preterm infants. Lancet 
1990;335:1491-1495.
27 Astrup J: Energy-requiring cell func­
tions in the ischaemic brain. J Neu­
rosurg 1982;56:482-497.
28 Benders MJNI, Van de Bor M, Van 
Bel F: Early effcct of indomethacin 
on cardiac and pulmonary hemody­
namics, Pediatr Res 1994;35:30A,
99
a
